Therapeutic Areas
Immunotherapy
Advanced biologicals for immune-system modulation.
As part of our strategic roadmap, Al Sumo is expanding into advanced immunotherapy and biological products, supported by GDP-aligned cold-chain infrastructure and a scientifically trained field force.
Market outlook
Immunological and biological therapies represent one of the fastest-developing hospital segments in Iraq, requiring specialized logistics and scientific engagement.
Partner opportunities
Partners with biological and immunotherapy pipelines benefit from our cold-chain capability, KOL relationships, and specialty-hospital access.
Current portfolio categories
- Biologicals
- Immune-modulation therapies
- Hospital specialty products
Scientific & commercial support
- Scientific detailing by trained medical representatives
- KOL engagement and advisory boards
- Regulatory registration and lifecycle management
- GDP-aligned warehousing and cold chain
- Nationwide distribution across 18 governorates
- Tender participation and hospital access
The information on this website is intended for general corporate and educational purposes. It does not replace professional medical advice, diagnosis, or treatment.